Payment overview · 2025
General Payments
2 reported records · 2 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · GARDENDALE, AL · NPI 1497167118
Verified facts
CMS Open Payments records show Joseph William Brewer, DO received $82.16 in general payments during 2025 across 2 reported records.
AERIN MEDICAL INC. accounted for 75.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 154 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
2 reported records · 2 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AERIN MEDICAL INC. | Unresolved — no canonical attribution shown | $62.00 | 75.5% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $20.16 | 24.5% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $82.16 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| RHINAER STYLUS Normalized: rhinaer stylus |
Device | AERIN MEDICAL INC. | $62.00 | 1 | 2025 |
Source payment records
|
|||||
| VIVAER STYLUS Normalized: vivaer stylus |
Device | AERIN MEDICAL INC. | $62.00 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $20.16 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $20.16 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 154 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
154 | 26 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 856 | 272 |
| Levothyroxine Sodium | Levothyroxine Sodium | 818 | 236 |
| Amlodipine Besylate | Amlodipine Besylate | 656 | 190 |
| Omeprazole | Omeprazole | 622 | 196 |
| Gabapentin | Gabapentin | 545 | 131 |
| Losartan Potassium | Losartan Potassium | 522 | 154 |
| Testosterone Cypionate | Testosterone Cypionate | 475 | 140 |
| Lisinopril | Lisinopril | 444 | 125 |
| Pantoprazole Sodium | Pantoprazole Sodium | 438 | 128 |
| Metformin Hcl Er | Metformin Hcl | 436 | 140 |
| Montelukast Sodium | Montelukast Sodium | 436 | 141 |
| Tamsulosin Hcl | Tamsulosin Hcl | 369 | 117 |
| Hydrochlorothiazide | Hydrochlorothiazide | 355 | 114 |
| Meloxicam | Meloxicam | 341 | 104 |
| Quetiapine Fumarate | Quetiapine Fumarate | 338 | 91 |
| Furosemide | Furosemide | 327 | 117 |
| Trazodone Hcl | Trazodone Hcl | 323 | 117 |
| Prednisone | Prednisone | 320 | 247 |
| Metoprolol Succinate | Metoprolol Succinate | 316 | 94 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 298 | 87 |
| Jardiance | Empagliflozin | 288 | 67 |
| Metformin Hcl | Metformin Hcl | 283 | 88 |
| Carvedilol | Carvedilol | 229 | 67 |
| Tizanidine Hcl | Tizanidine Hcl | 229 | 60 |
| Zolpidem Tartrate | Zolpidem Tartrate | 226 | 44 |
| Mounjaro | Tirzepatide | 221 | 36 |
| Simvastatin | Simvastatin | 214 | 64 |
| Pravastatin Sodium | Pravastatin Sodium | 211 | 56 |
| Methocarbamol | Methocarbamol | 210 | 81 |
| Alendronate Sodium | Alendronate Sodium | 209 | 66 |
| Azithromycin | Azithromycin | 206 | 164 |
| Allopurinol | Allopurinol | 201 | 58 |
| Escitalopram Oxalate | Escitalopram Oxalate | 191 | 64 |
| Potassium Chloride | Potassium Chloride | 175 | 59 |
| Sertraline Hcl | Sertraline Hcl | 171 | 47 |
| Duloxetine Hcl | Duloxetine Hcl | 167 | 46 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 160 | 46 |
| Ozempic | Semaglutide | 154 | 26 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 143 | 50 |
| Liothyronine Sodium | Liothyronine Sodium | 142 | 48 |
| Celecoxib | Celecoxib | 141 | 37 |
| Ondansetron Odt | Ondansetron | 133 | 43 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 126 | 39 |
| Citalopram Hbr | Citalopram Hydrobromide | 125 | 36 |
| Eliquis | Apixaban | 124 | 28 |
| Atenolol | Atenolol | 122 | 35 |
| Glimepiride | Glimepiride | 121 | 40 |
| Buspirone Hcl | Buspirone Hcl | 120 | 31 |
| Donepezil Hcl | Donepezil Hcl | 119 | 33 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 116 | 110 |
| Famotidine | Famotidine | 116 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 114 | 36 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 111 | 31 |
| Fluoxetine Hcl | Fluoxetine Hcl | 109 | 25 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 107 | 66 |
| Metoprolol Tartrate | Metoprolol Tartrate | 103 | 34 |
| Ropinirole Hcl | Ropinirole Hcl | 100 | 30 |
| Clopidogrel | Clopidogrel Bisulfate | 98 | 31 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 97 | 30 |
| Bupropion Xl | Bupropion Hcl | 93 | 28 |
| Promethazine Hcl | Promethazine Hcl | 93 | 23 |
| Spironolactone | Spironolactone | 92 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 89 | 34 |
| Amitriptyline Hcl | Amitriptyline Hcl | 85 | 23 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 85 | 31 |
| Pioglitazone Hcl | Pioglitazone Hcl | 85 | 20 |
| Clonidine Hcl | Clonidine Hcl | 84 | 20 |
| Ezetimibe | Ezetimibe | 83 | 26 |
| Alprazolam | Alprazolam | 80 | 13 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 79 | 75 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 79 | 47 |
| Valacyclovir | Valacyclovir Hcl | 78 | 29 |
| Clonazepam | Clonazepam | 77 | 18 |
| Dicyclomine Hcl | Dicyclomine Hcl | 76 | 27 |
| Synthroid | Levothyroxine Sodium | 76 | 15 |
| Fenofibrate | Fenofibrate | 73 | 23 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 73 | 21 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 73 | 22 |
| Mirtazapine | Mirtazapine | 72 | 21 |
| Fluconazole | Fluconazole | 70 | 51 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 70 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 68 | 19 |
| Ibuprofen | Ibuprofen | 64 | 16 |
| Tramadol Hcl | Tramadol Hcl | 64 | 35 |
| Linzess | Linaclotide | 62 | 28 |
| Paroxetine Hcl | Paroxetine Hcl | 62 | 16 |
| Lorazepam | Lorazepam | 61 | 17 |
| Pregabalin | Pregabalin | 61 | 13 |
| Januvia | Sitagliptin Phosphate | 60 | 16 |
| Benazepril Hcl | Benazepril Hcl | 59 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 58 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 56 | 18 |
| Meclizine Hcl | Meclizine Hcl | 55 | 26 |
| Topiramate | Topiramate | 54 | 19 |
| Cephalexin | Cephalexin | 53 | 50 |
| Propranolol Hcl | Propranolol Hcl | 52 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 49 | 42 |
| Lovastatin | Lovastatin | 49 | 16 |
| Memantine Hcl | Memantine Hcl | 49 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 48 | 15 |
| Sucralfate | Sucralfate | 47 | 17 |
| Doxepin Hcl | Doxepin Hcl | 46 | 15 |
| Cefdinir | Cefdinir | 43 | 40 |
| Farxiga | Dapagliflozin Propanediol | 43 | suppressed |
| Lansoprazole | Lansoprazole | 43 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 43 | 35 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 43 | 35 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 41 | 12 |
| Levetiracetam | Levetiracetam | 40 | 11 |
| Telmisartan | Telmisartan | 40 | 11 |
| Warfarin Sodium | Warfarin Sodium | 40 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 39 | 12 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 39 | suppressed |
| Temazepam | Temazepam | 37 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 36 | 11 |
| Valsartan | Valsartan | 36 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 35 | 12 |
| Glipizide Er | Glipizide | 33 | suppressed |
| Nystatin | Nystatin | 33 | 20 |
| Trulicity | Dulaglutide | 33 | suppressed |
| Naproxen | Naproxen | 32 | 11 |
| Baclofen | Baclofen | 31 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 24 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | 11 |
| Lidocaine | Lidocaine | 29 | suppressed |
| Primidone | Primidone | 29 | suppressed |
| Repaglinide | Repaglinide | 29 | suppressed |
| Colchicine | Colchicine | 28 | 13 |
| Colestipol Hcl | Colestipol Hcl | 28 | suppressed |
| Estradiol | Estradiol | 28 | suppressed |
| Xarelto | Rivaroxaban | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Glipizide | Glipizide | 27 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 27 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 26 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 26 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 26 | 19 |
| Metoclopramide Hcl | Metoclopramide Hcl | 26 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 25 | suppressed |
| Anastrozole | Anastrozole | 24 | 14 |
| Symbicort | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Clonidine | Clonidine | 23 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 23 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 23 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 22 | 21 |
| Hydrocortisone | Hydrocortisone | 22 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 21 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Metronidazole | Metronidazole | 20 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Indapamide | Indapamide | 19 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | suppressed |
| Ramipril | Ramipril | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 14 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 18 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Eszopiclone | Eszopiclone | 17 | suppressed |
| Etodolac | Etodolac | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 17 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 16 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 16 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 16 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Finasteride | Finasteride | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 15 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 15 | 15 |
| Irbesartan | Irbesartan | 15 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Cholestyramine Light | Cholestyramine | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | 12 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Tadalafil | Tadalafil | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Np Thyroid | Thyroid,pork | 11 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Testosterone | Testosterone | 11 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $82.16 · 2 records | AERIN MEDICAL INC. | Ozempic, RHINAER STYLUS, Rybelsus, VIVAER STYLUS | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error